Patents Assigned to Askton Bioscences Corporation
  • Ultra-long acting insulin-Fc fusion protein and methods of use
    Patent number: 11192930
    Abstract: The present disclosure relates to compositions of insulin-Fc fusion proteins and their use to treat feline diabetes.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: December 7, 2021
    Assignee: Askton Bioscences Corporation
    Inventors: Thomas M. Lancaster, Todd C. Zion